Company Filing History:
Years Active: 2025
Title: Kenneth Harder: Innovator in Anti-G-CSF Antibodies
Introduction
Kenneth Harder is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of anti-G-CSF antibodies. His work has the potential to impact various therapeutic applications.
Latest Patents
Kenneth Harder holds a patent for "Anti-G-CSF antibodies and uses thereof." This patent discloses methods for making anti-G-CSF antibodies, as well as their applications in treating diseases. The patent also includes methods for screening the activity of these antibodies, pharmaceutical compositions, and kits containing anti-G-CSF antibodies.
Career Highlights
Kenneth is associated with Me Therapeutics Inc., where he continues to advance his research and development efforts. His innovative work in the field of antibodies showcases his commitment to improving healthcare solutions.
Collaborations
Kenneth has collaborated with notable colleagues, including Salim Dhanji and John Priatel. These partnerships enhance the research environment and foster innovation within the company.
Conclusion
Kenneth Harder is a distinguished inventor whose work on anti-G-CSF antibodies represents a significant advancement in biotechnology. His contributions are poised to make a lasting impact on therapeutic practices.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.